Literature DB >> 33668021

NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021.

David S Ettinger1, Douglas E Wood2, Dara L Aisner3, Wallace Akerley4, Jessica R Bauman5, Ankit Bharat6, Debora S Bruno7, Joe Y Chang8, Lucian R Chirieac9, Thomas A D'Amico10, Thomas J Dilling11, Jonathan Dowell12, Scott Gettinger13, Matthew A Gubens14, Aparna Hegde15, Mark Hennon16, Rudy P Lackner17, Michael Lanuti18, Ticiana A Leal19, Jules Lin20, Billy W Loo21, Christine M Lovly22, Renato G Martins2, Erminia Massarelli23, Daniel Morgensztern24, Thomas Ng25, Gregory A Otterson26, Sandip P Patel27, Gregory J Riely28, Steven E Schild29, Theresa A Shapiro1, Aditi P Singh30, James Stevenson7, Alda Tam8, Jane Yanagawa31, Stephen C Yang1, Kristina M Gregory32, Miranda Hughes32.   

Abstract

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) address all aspects of management for NSCLC. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines regarding targeted therapies, immunotherapies, and their respective biomarkers.

Entities:  

Year:  2021        PMID： 33668021     DOI： 10.6004/jnccn.2021.0013

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


  182 in total

1.  Efficacy of cisplatin plus vinorelbine adjuvant chemotherapy with split-dose administration of cisplatin after complete resection of stage II-IIIA non-small cell lung cancer.

Authors:  Norihiko Funaguchi; Hirotoshi Iihara; Daizo Kaito; Takenori Gomyo; Yuka Sasaki; Komei Yanase; Junki Endo; Fumitaka Ito; Chiemi Hirose; Yasushi Ohno; Hiroyuki Okura
Journal:  Mol Clin Oncol       Date:  2022-02-07

Review 2.  Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients.

Authors:  Subasri Armon; Paul Hofman; Marius Ilié
Journal:  Cells       Date:  2021-07-29       Impact factor: 6.600

3.  Disparate Access to Surgery for Operable Carcinoma of the Lung in North Carolina.

Authors:  Aundrea L Oliver; Caitlin Takahashi-Pipkin; Jan H Wong; Ashley E Burch; William D Irish
Journal:  Ann Surg Oncol       Date:  2022-07-09       Impact factor: 4.339

Review 4.  Older Patients with Lung Cancer: a Summary of Seminal Contributions to Optimal Patient Care.

Authors:  Alina Basnet; Asrar Alahmadi; Ajeet Gajra
Journal:  Curr Oncol Rep       Date:  2022-07-28       Impact factor: 5.945

Review 5.  PD-1/PD-L1 inhibitors in treatment-naïve, advanced non-small cell lung cancer patients with < 1% PD-L1 expression: a meta-analysis of randomized controlled trials.

Authors:  Durgesh Wankhede; Paul Hofman; Sandeep Grover
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-19       Impact factor: 4.322

6.  Predictive value of intratumor metabolic and heterogeneity parameters on [18F]FDG PET/CT for EGFR mutations in patients with lung adenocarcinoma.

Authors:  Ming Ni; Shicun Wang; Xin Liu; Qin Shi; Xingxing Zhu; Yifan Zhang; Qiang Xie; Weifu Lv
Journal:  Jpn J Radiol       Date:  2022-10-11       Impact factor: 2.701

Review 7.  A narrative review of advances in treatment and survival prognosis of HER2-positive malignant lung cancers.

Authors:  Ranpu Wu; Bingxiao Yuan; Chuling Li; Zimu Wang; Yong Song; Hongbing Liu
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

8.  Long non-coding RNA ANRIL promotes homologous recombination-mediated DNA repair by maintaining ATR protein stability to enhance cancer resistance.

Authors:  Lei Liu; Yuanyuan Chen; Yijuan Huang; Kun Cao; Tingting Liu; Hui Shen; Jianguo Cui; Bailong Li; Jianming Cai; Fu Gao; Yanyong Yang
Journal:  Mol Cancer       Date:  2021-07-05       Impact factor: 27.401

9.  A Multicenter Retrospective Study on the Prognosis of Stage III Unresectable Mutant Non-Small Cell Lung Cancer With Tyrosine Kinase Inhibitors Therapy.

Authors:  Ranpu Wu; Shaorong Yu; Jinjun Ye; Yimin Wang; Zhiting Zhao; Hongbing Liu; Yong Song
Journal:  Front Oncol       Date:  2021-07-12       Impact factor: 6.244

10.  Development and validation of tumor-to-blood based nomograms for preoperative prediction of lymph node metastasis in lung cancer.

Authors:  Yili Fu; Xiaoying Xi; Yanhua Tang; Xin Li; Xin Ye; Bin Hu; Yi Liu
Journal:  Thorac Cancer       Date:  2021-06-24       Impact factor: 3.500
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.